Proteins and nucleic acids useful in vaccines targeting Staphylococcus aureus Grant US-11807669-B2 United States of America 07 Nov 2023
TOLEROGENIC SYNTHETIC NANOCARRIERS FOR ANTIGEN-SPECIFIC DELETION OF T EFFECTOR CELLS Application EP-3871691-A1 European Patent Office 01 Sep 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE CYTOTOXIC T LYMPHOCYTE RESPONSES Application EP-3848030-A1 European Patent Office 14 Jul 2021
TOLEROGENIC SYNTHETIC NANOCARRIERS TO REDUCE ANTIBODY RESPONSES Application EP-3760201-A1 European Patent Office 06 Jan 2021